Office of Research
Pacific Northwest Udall Center
The Pacific Northwest Udall Center (PANUC; pronounced “pa NOOK”), is one of nine Morris K. Udall Centers of Excellence for Parkinson’s Disease Research. Udall Centers are funded by the National Institutes of Health (NIH) to conduct research into the cause(s) of Parkinson’s disease and to improve the diagnosis and treatment of patients with Parkinson’s disease and related neurodegenerative disorders. PANUC is a collaboration among the University of Washington, the VA Puget Sound Health Care System, Oregon Health & Science University, and the Portland VA Medical Center. This multidisciplinary program brings together academic, clinical, and research experts in the fields of movement disorders, memory disorders, and brain aging to study cognitive impairment in Parkinson’s disease.
Core Services Offered
Cognitive Function Assessments: Cognitive impairment is common in Parkinson's disease. It is a significant source of disability for people with Parkinson's disease and causes increased burden for caregivers. The primary research focus of PANUC is cognitive impairment in Parkinson's disease. Through both clinical and basic research, we strive to understand the basis of this problem and to discover new and better treatments for all people with Parkinson's disease.
Genetic Research: Genetics plays an important role in determining who will develop Parkinson's disease and which symptoms each person will experience. PANUC investigators are trying to find genes that influence the risk of developing cognitive impairment in Parkinson's disease and this will point us to new therapeutic targets.
Biomarker Testing: As we and others work to develop better treatments, it also will be necessary to develop tools to determine their effectiveness. PANUC biomarker research will address this problem by developing laboratory tests to estimate risk, aid in diagnosis, measure progression, and determine the response to treatment.
Experimental Medication Protocols: PANUC investigators are seeking novel treatment trials for Parkinson's disease and related disorders, particularly those related to cognitive impairment in Parkinson's disease. Volunteers in PANUC will have the opportunity to participate in these studies as they become available.
National Institutes of Health (NIH)